Open AccessEvaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19
Author(s) -
Andreas BarrattDue,
Inge Christoffer Olsen,
Kateřiezvalová-Henriksen,
Trine Kåsine,
Fridtjof Lund-Johansen,
Hedda Hoel,
Aleksander Rygh Holten,
Anders Aune Tveita,
Alexander Mathiessen,
Mette Haugli,
Ragnhild Eiken,
Anders Benjamin Kildal,
Åse Berg,
Asgeir Johannessen,
Lars Heggelund,
Tuva B. Dahl,
Karoline H Skåra,
Paweł Mielnik,
Lan Ai Kieu Le,
Lars Thoresen,
Gernot Ernst,
Dag Arne Lihaug Hoff,
Hilde Skudal,
Bård Reiakvam Kittang,
Roy Bjørkholt Olsen,
Birgitte Tholin,
Carl Magnus Ystrøm,
Nina Vibeche Skei,
Trung Tran,
Susanne Dudman,
Jan Terje Andersen,
Raisa Hannula,
Olav Dalgård,
AneKristine Finbråten,
Kristian Tonby,
Bjørn Blomberg,
Saad Aballi,
Cathrine Fladeby,
Anne Katrine Steffensen,
Fredrik Müller,
Anne Ma DyrholRiise,
Marius Trøseid,
Pål Aukrust
Publication year - 2021
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m21-0653
Subject(s) - medicine , hydroxychloroquine , viral load , randomized controlled trial , respiratory system , covid-19 , immunology , virus , disease , infectious disease (medical specialty)
New treatment modalities are urgently needed for patients with COVID-19. The World Health Organization (WHO) Solidarity trial showed no effect of remdesivir or hydroxychloroquine (HCQ) on mortality, but the antiviral effects of these drugs are not known.